Digital health company Eko has introduced the new SENSORA cardiovascular disease detection platform, which will help identify non-invasive heart disease.
The SENSORA platform features artificial intelligence (AI) that objectively detects structural murmurs, which can be an indication of valvular heart disease (VHD).
The cardiac disease detection platform also includes Care Pathway Analytics software, which offers downstream visibility and metrics of the healthcare system journey for each patient.
By following patients with identified structural murmurs, the software provides downstream visibility into clinical outcomes, patient flows and economics.
As an enterprise-grade digital stethoscope platform, SENSORA enables health systems to precisely detect VHD in patients through structural murmur detection during routine visits to their primary care physician.
If left undetected and untreated, VHD may result in heart failure, stroke, blood clots and death.
Eko co-founder and CEO Connor Landgraf said: “Our vision for SENSORA is to make cardiovascular disease detection simple and accurate in frontline care settings like primary care and urgent care.
“During a routine physical exam, patients can now have access to advanced structural murmur detection and arrhythmia assessment by their primary care physician in seconds, making early intervention possible for millions of patients with silent cardiovascular disease.”
The company is also involved in the development of two machine-learning algorithms that would use an electrocardiogram (ECG) and heart sound data to identify a weakened heart pump.
Last August, Eko collaborated with enterprise telehealth platform provider Caregility to bring smart stethoscope technology to telehealth platforms.
The collaboration focused on the seamless integration of Caregility’s cloud platform with Eko’s smart stethoscopes and software.